rs104893916
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM1PM2PP3_ModeratePP5_Very_Strong
The NM_000112.4(SLC26A2):c.2033G>T(p.Gly678Val) variant causes a missense change. The variant allele was found at a frequency of 0.000013 in 1,613,982 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G678L) has been classified as Uncertain significance.
Frequency
Consequence
NM_000112.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SLC26A2 | NM_000112.4 | c.2033G>T | p.Gly678Val | missense_variant | 3/3 | ENST00000286298.5 | |
SLC26A2 | XM_017009191.3 | c.2033G>T | p.Gly678Val | missense_variant | 3/4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SLC26A2 | ENST00000286298.5 | c.2033G>T | p.Gly678Val | missense_variant | 3/3 | 1 | NM_000112.4 | P1 | |
SLC26A2 | ENST00000503336.1 | c.372+3275G>T | intron_variant | 3 |
Frequencies
GnomAD3 genomes ? AF: 0.0000197 AC: 3AN: 152164Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251126Hom.: 0 AF XY: 0.00000737 AC XY: 1AN XY: 135712
GnomAD4 exome AF: 0.0000123 AC: 18AN: 1461818Hom.: 0 Cov.: 34 AF XY: 0.0000151 AC XY: 11AN XY: 727200
GnomAD4 genome ? AF: 0.0000197 AC: 3AN: 152164Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74324
ClinVar
Submissions by phenotype
Multiple epiphyseal dysplasia type 4 Pathogenic:1
Likely pathogenic, criteria provided, single submitter | literature only | Counsyl | Mar 16, 2014 | - - |
Achondrogenesis, type IB Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Jan 01, 1996 | - - |
Osteochondrodysplasia Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | May 01, 2023 | Variant summary: SLC26A2 c.2033G>T (p.Gly678Val) results in a non-conservative amino acid change located in the STAS domain (IPR002645) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 4e-06 in 251126 control chromosomes. c.2033G>T has been reported in the literature as a compound heterozygous genotype with a null allele in at-least one individual affected with Sulfate Transporter-Related Osteochondrodysplasia (example, Karniski_2001 citing Superti-Furga_1996). Multiple publications report experimental evidence evaluating an impact on protein function (example, Karniski_2001, Karniski_2004, Rapp_2019). The most pronounced variant effect results in <10% of normal sulfate transport activity in-vitro when analyzed in mammalian cell system (Karniski_2004) however retained partial function when expressed in Xenopus oocytes (Karniski_2001). Another recent study reported ER retention and degradation by ER-associated degradation (ERAD) (Rapp_2019). The following publications have been ascertained in the context of this evaluation (PMID: 11448940, 15294877, 30462520, 8723100). No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as likely pathogenic. - |
Diastrophic dysplasia Other:1
not provided, no classification provided | literature only | GeneReviews | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at